Find clinical trials for Lung Cancer in Pittsburgh, PA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma

Cancer

Carcinoma

Small Cell Lung Carcinoma

Squamous Cell Carcinoma of Head and Neck

Triple Negative Breast Cancer

Colorectal Cancer

Lung Cancer trials near Pittsburgh, PA, USA:

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non-small-cell lung...

Enrolling

Metastatic Non Small Cell Lung Cancer

Biological: LN-145

Phase 2

Iovance Biotherapeutics

Natrona Heights, Pennsylvania, United States and 48 other locations

Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung Cancer

This phase II clinical trial will study the safety and efficacy of onvansertib to treat patients with small cell lung cancer (SCLC)...

Enrolling

Small-cell Lung Cancer

Small Cell Lung Carcinoma

Drug: Onvansertib

Phase 2

Taofeek Owonikoko

Pittsburgh, Pennsylvania, United States and 1 other location

Study to Evaluate Monotherapy and Combination Immunotherapies in Participants With PD-L1 Positive Non-small Cell Lung Cancer (ARC-7)

and domvanalimab in combination with zimberelimab and etrumadenant (AB928) in front-line, PD-L1 positive, metastatic non-small cell lung cancer...

Active, not recruiting

Squamous Non Small Cell Lung Cancer

Nonsquamous Non Small Cell Lung Cancer

Drug: Etrumadenant

Drug: Zimberelimab

Phase 2

Arcus Biosciences

Pittsburgh, Pennsylvania, United States and 46 other locations

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

the efficacy and safety of an infusion of IOV-4001 in adult participants with unresectable or metastatic melanoma or advanced non-small-cell lung...

Enrolling

Stage III Non-small Cell Lung Cancer

Stage IV Non-small Cell Lung Cancer

Biological: IOV-4001

Phase 1, Phase 2

Iovance Biotherapeutics

Pittsburgh, Pennsylvania, United States and 9 other locations

U3-1402 in Metastatic or Unresectable Non-Small Cell Lung Cancer

locally advanced or metastatic disease.In addition, HER3-DXd will be evaluated in participants with locally advanced or metastatic NSCLC whose tumors...

Enrolling

Non-Small Cell Lung Cancer (NSCLC)

Drug: HER3-DXd (FL-DP)

Drug: HER3-DXd (CTM-3 Lyo-DP)

Phase 1